Skip to main content
Clinical Trials/NCT05922605
NCT05922605RecruitingPhase 4

Analgesic Effects of Caudal S-ketamine for Supplementation of Ropivacaine Caudal Analgesia in Children With Hypospadias

Tao Zhang1 site in 1 country44 target enrollmentStarted: June 20, 2023Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
44
Locations
1
Primary Endpoint
duration of caudal analgesia

Study Overview

Brief Summary

Caudal analgesia with ropivacaine is commonly used in sub-umbilical pediatric surgery. However, increasing the dosage of ropivacaine has not been found to prolong the action significantly while complications will be serious.

Ketamine as an additive to caudal administration had been shown to prolong the duration of postoperative analgesia, while the analgesic effectiveness of S-ketamine, the S(+)-enantiomer of ketamine with less possibility to induce psychomotor disturbances, is not clear. In this prospective randomized double-blind clinical trial , the investigators aimed to study the effect of S-ketamine as additive on the duration of caudal analgesia.

Detailed Description

Forty-four children scheduled for hypospadias randomize into 2 groups. Group E (n=22) (0.2% ropivacaine 0.7 ml/kg and S-ketamine 0.5 mg/kg), group C(n=22)( 0.2%ropivacaine 0.7ml/kg and equivalent saline) intraoperative and postoperative hemodynamics will be recorded. Postoperative pain is assessed using an established 6-item FLACC score at 1h,3h,6h,12h,24h,48h, or the time when children complain of pain after surgery. A score of more15μg/kg is administered.Investigators propose to compare the duration of caudal analgesia provided by plain ropivacaine and by a mixture of ropivacaine and S-ketamine.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Masking Description

The Patients allocated to study groups using computer generates random list & group assignment is sealed in sequentially numbered opaque envelopes that open after induction of anesthesia.

Eligibility Criteria

Ages
3 Months to 18 Years (Child, Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • informed parent consent, ASA I or II children, between 3months and 18 years of age,and weighing <28kg, scheduled for elective hypospadias surgery with general anesthesia will be recruited.

Exclusion Criteria

  • Patients who have congenital abnormalities of lower spine and meninges.
  • Patients with hypersensitivity to any local anesthetics
  • Children with coagulation disorders
  • Presence of Infections at puncture sites
  • Preexisting neurological disease
  • Refusal to consent by parent/guardian

Arms & Interventions

Group E

Experimental

the children are given a mixture of 0.2%ropivacaine 0.7 ml/kg and preservative-free S-ketamine 0.5 mg/kg for caudal analgesia.

Intervention: S-ketamine & Ropivacaine (Drug)

Group C

Active Comparator

The children are given 0.2%ropivacaine 0.7 ml/kg and saline of equal volume caudally.

Intervention: Ropivacaine (Drug)

Outcomes

Primary Outcomes

duration of caudal analgesia

Time Frame: 48 hours after the caudal injection

Duration of analgesia is defined as the time from caudal injection to the first need for systemic analgesia.

Secondary Outcomes

  • FLACC score(48 hours after the caudal block)
  • morphine consumption(48 hours after caudal block)
  • complication(48 hours after the caudal block)

Investigators

Sponsor
Tao Zhang
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Tao Zhang

Associate Professor

First Affiliated Hospital, Sun Yat-Sen University

Study Sites (1)

Loading locations...

Similar Trials